Library
1BP-LSD
1BP-LSD, also known as 1-(3- propionyl)-LSD, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD). It is thought to be a prodrug of LSD. The drug was encountered online as a novel designer drug in December 2025. 1BP-LSD has been sold in the form of blotter containing 175 and 200 μg per tab. It has been said to be considered to be the official legal successor of 1S-LSD, which was banned in Germany soon before 1BP-LSD's appearance. The effects of 1BP-LSD are said to be similar to those of 1S-LSD and to include visual changes, altered perception of time and space, heightened emotions, and increased creativity. 1BP-LSD is not an explicitly controlled substance in the United States or in Canada.
Classification
- Chemical: Lysergamide
- Psychoactive: Psychedelic
Effects
- Dilated Pupils
- Pupil Dilation
- Stimulation
- Nausea
- Spontaneous Tactile Sensations
- Physical Euphoria
- Introspection
- Euphoria
- Time Distortion
- Conceptual Thinking
- Novelty Enhancement
- Analysis Enhancement
- Visual Distortions
- Color Enhancement
- Drifting
- Tracers
- Pattern Recognition Enhancement
- Hallucinations
Routes of Administration
No route information available yet.
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
Links
This static page is intended as a readable non-JS and prerender-friendly library export.
